Company Profile
Jumpspace Ventures is an early-stage venture capital firm dedicated to investing in neurotechnology devices for the future of humanity. The firm champions neural breakthroughs, focusing on innovative brain-computer interfaces (BCI) and other medical devices related to the brain and nervous system. Their investment thesis centers on advancing technologies that address critical needs in healthcare and human performance, aiming to support companies at the forefront of neurotech innovation.
Founded in 2023, Jumpspace Ventures was established in New York with a clear mission to identify and nurture promising startups in the burgeoning neurotechnology sector. The firm seeks to provide capital and strategic support to companies developing cutting-edge solutions that can significantly impact human health and capabilities. Adam Caplan serves as the Founder and General Partner, bringing his experience to guide the firm's investment strategy.
The firm's portfolio showcases a diverse range of neurotech companies. Notable investments include Connectome, which focuses on brain biometric data for performance and longevity; Coherence, developing therapeutic BCIs for oncology; and Ampa Health, working on transcranial magnetic stimulation for mental health. Other portfolio companies span areas such as focused ultrasound technology, biological cloud computing platforms, and advanced neural interfaces, demonstrating Jumpspace Ventures' broad commitment to the neurotech landscape.
The team at Jumpspace Ventures, led by Adam Caplan, leverages expertise in venture capital and the neurotechnology domain to identify and support high-potential ventures. Their approach involves active engagement with portfolio companies, providing guidance beyond just capital to help accelerate the development and market adoption of groundbreaking neurotech solutions.
News & Signals (0)
No linked news activity found for this company.